JFL Life Sciences (NSE:JFLLIFE) Cash Flow from Discontinued Operations: ₹0.0 Mil (TTM As of Mar. 2025)


NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
66 GF Score
Price ₹9.05
GF Value ₹35.51
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JFL Life Sciences Cash Flow from Discontinued Operations?

JFL Life Sciences NSE:JFLLIFE 66 Cash Flow from Discontinued Operations is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 66/100 and a GF Value™ of ₹35.51 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

JFL Life Sciences's cash flow from discontinued operations for the six months ended in Mar. 2025 was ₹0.0 Mil. It means JFL Life Sciences received ₹0.0 Mil from the sale of part of business quarterly. JFL Life Sciences's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

JFL Life Sciences Cash Flow from Discontinued Operations Related Terms

JFL Life Sciences Cash Flow from Discontinued Operations Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences Cash Flow from Discontinued Operations Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cash Flow from Discontinued Operations Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:JFLLIFE
66GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
Cash Flow from Discontinued Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Discontinued Operations of ₹0.0 Mil mean?
JFL Life Sciences (NSE:JFLLIFE) has a Cash Flow from Discontinued Operations of ₹0.0 Mil as of Mar. 2025. Cash Flow from Discontinued Operations is the amount of cash earned from ceased operations. View historical data for Apple Inc and its JFL Life Sciences.
Is JFL Life Sciences' Cash Flow from Discontinued Operations too high?
JFL Life Sciences' current Cash Flow from Discontinued Operations is ₹0.0 Mil. Overall, JFL Life Sciences has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Cash Flow from Discontinued Operations compare to ZTS?
JFL Life Sciences' Cash Flow from Discontinued Operations of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Discontinued Operations for a Drug Manufacturers company?
A good Cash Flow from Discontinued Operations depends on the Drug Manufacturers industry context. However, Cash Flow from Discontinued Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Discontinued Operations mean?
A high Cash Flow from Discontinued Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Discontinued Operations is the amount of cash earned from ceased operations. View historical data for Apple Inc and its JFL Life Sciences. JFL Life Sciences's current Cash Flow from Discontinued Operations is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.51, compared to a current price of ₹9.05 — trading 74.5% below its estimated fair value. The current Cash Flow from Discontinued Operations is ₹0.0 Mil. JFL Life Sciences' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Discontinued Operations calculated?
Cash Flow from Discontinued Operations is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Cash Flow from Discontinued Operations is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹9.05 is trading 74.5% below its estimated GF Value™ of ₹35.51. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • Cash Flow from Discontinued Operations: ₹0.0 Mil
  • GF Value™: ₹35.51 vs. price of ₹9.05 (74.5% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
66GF Score

Get the complete analysis for NSE:JFLLIFE

Cash Flow from Discontinued Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.05
Price
₹35.51
GF Value